Galena Biopharma to Present at the 12th Annual Needham Healthcare Conference

        Print
| Source: Galena Biopharma

LAKE OSWEGO, Ore., April 24, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today announced that Mark J. Ahn, Ph.D., President and Chief Executive Officer, will present a corporate update at the 12th Annual Needham Healthcare Conference. The presentation will take place on Wednesday, May 1, 2013 at 1:40 p.m. ET at the Westin Grand Central Hotel in New York, NY.

The presentation will be webcast and available on the Investors section of the Company's website at www.galenabiopharma.com.

About Galena Biopharma

Galena Biopharma, Inc. (Nasdaq:GALE) is a Portland, Oregon-based biopharmaceutical company developing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. For more information please visit us at www.galenabiopharma.com.

Madeline Hatton
Toll free: +1 (855) 855-GALE (4253), ext. 109


Or

Remy Bernarda
+1 (503) 400-6995